BronchiectasisNCT06630403
Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis
An observational study of Bronchiectasis, run by Atlas University at 1 site in Turkey (Türkiye).
Trial summary
The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers. Read more about this study
- Who is it for?
- Ages 7 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Bronchiectasis
- What is being tested?
- Demographic Data, Disease History and Pulmonary Function Test
- How many people
- 40 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 5 Sep 2023to 1 Jan 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 7 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: Twenty patients with bronchiectasis and 20 healthy individuals who met the inclusion criteria applied to the study. The study consisted of 2 groups, experimental and control.
Who may be able to join
- Diagnosed with cystic or non-cystic bronchiectasis
- Being clinically stable
- Not having an exacerbation or infection
- Being between the ages of 7-18
- To be able to read and understand Turkish
Who cannot join
- Unstable concomitant cardiac, orthopedic or neurologic disease
- History of previous lung or liver transplantation
- History of acute exacerbation and/or hospitalization in the last 1 month
- Changes in medical treatment during the study period.
Trial locations and contacts
1 site in 1 country.
About this study
The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.
Read the detailed description
The main causes affecting exercise capacity in patients with bronchiectasis are restriction of tidal expiratory flow, dyspnea secondary to dynamic hyperinflation, changes in pulmonary mechanics, inadequate gas exchange and decreased skeletal muscle mass. Due to all these symptoms, exercise capacity decreases in patients with bronchiectasis and the importance of physical activity increases. . In addition to decreased exercise capacity in individuals with bronchiectasis, studies on the effect of motor imagery ability, which is considered as a mental exercise, have not been found. Inadequate blood supply to the brain and muscle dysfunction have been reported to cause cognitive damage and decreased reaction time in COPD patients.
- Conditions
- Bronchiectasis
- Being tested
- Demographic Data, Disease History, Pulmonary Function Test, Reaction Time, Functional Capacity
- Keywords
- bronchiectasis, cognitive function, motor imagery
- Medical subject headings
- Bronchiectasis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Demographic DataOther
Demographic data (age, height, weight, BMI) will be collected verbally through an assessment form.
Disease HistoryOther
The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned.
Pulmonary Function TestOther
Pulmonary Function Test will be performed with a spirometer.
Reaction TimeOther
Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
Functional CapacityOther
Functional capacity will be evaluated with 6 minute walk test
Dyspnea PerceptionOther
Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea
Quality of LifeOther
Quality of life will be assessed with the "Quality of Life Scale for Children\"
Fear of movementOther
Fear of movement will be evaluated with Tampa Kinesiophobia Scale
Ability of Motor ImageryOther
Motor Imagery ability will be assessed by Movement Imagery Questionnaire-3 and Vividness of Movement Imagery
Cognitive FunctionsOther
Cognitive functions will be assessed with Trail Making Test and Stroop Test
| Study group | Role | What they receive |
|---|---|---|
| Children with Bronchiectasis Experiment Group | Children with bronchiectasis Participants will be required to sign an informed consent form before the evaluation.
Assesment Methods:
1. Demographic data will be collected verbally.
2. The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned.
3. Pulmonary Function Test will be applied.
4. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
5. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test.
6. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea.
7. Quality of life will be assessed with the "Quality of Life Scale for Children".
8. Fear of movement will be assessed with the Tampa Kinesiophobia Scale.
9. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery.
10. Cognitive functions will be assessed with Trail Making Test and Stroop Test. Receives: Other: Demographic Data; Other: Disease History; Other: Pulmonary Function Test; Other: Reaction Time; Other: Functional Capacity; Other: Dyspnea Perception; Other: Quality of Life; Other: Fear of movement; Other: Ability of Motor Imagery; Other: Cognitive Functions | |
| Healthy Controls | Healthy Peers
Participants will be required to sign an informed consent form before the evaluation.
Assessment Methods:
1. Demographic data (age, height, weight, BMI) will be collected verbally via the assessment form.
2. Pulmonary Function Test will be applied.
3. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test.
4. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test.
5. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea.
6. Quality of life will be assessed with the "Quality of Life Scale for Children".
7. Fear of movement will be assessed with the Tampa Kinesiophobia Scale.
8. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery.
9. Cognitive functions will be assessed with Trail Making Test and Stroop Test. Receives: Other: Demographic Data; Other: Pulmonary Function Test; Other: Reaction Time; Other: Functional Capacity; Other: Dyspnea Perception; Other: Quality of Life; Other: Fear of movement; Other: Ability of Motor Imagery; Other: Cognitive Functions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Trail Making Test
The Trail Making Test is divided into two parts. In the first part, the participant is asked to connect the 23 numbers in the circle randomly placed on the page with a pencil in an orderly order, and in the second part, the participant is asked to draw and connect the 23 numbers and letters in the circle in a mixed order. In the second part, the individual has to change sets between one letter and one number. (1- A, 2-B, 3-C, 4-D, etc.).The test can be applied between the ages of 8-79.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Stroop Test
The Stroop Test consists of four parts. The first part contains words written in black (e.g blue), the second part contains colors and the last part contains words written in different colors (e.g. the word blue written in red ink). The participant is expected to fulfill these tasks in turn. The participant has to correctly read the words in the first part, say the colors in the next part, read the colored word in the third part, and then say the color in which the word is written in the last part.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Nelson Hand Reaction Test
The tester holds the ruler by the tip and between the thumb and index fingers of the subject and releases the ruler. When the ruler is released, the participant is asked to catch the ruler. The participants hand is fixed and 20 trials are performed in the test. At the top point where the subject grabs the ruler with his/her fingers, the reaction time of the subject is determined. The highest and lowest five trials are discarded and the remaining ones are averaged.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Nelson Foot Reaction Test
The participant removes his/her shoes and sits with the toe 2.5 cm from the wall and the heel 5 cm. The tester holds the reaction time ruler at the edge of the wall and between the wall and the subjects foot, with the baseline at the tip of the thumb. The subject is instructed to look at the concentration line and to hold the ruler, which falls after the ready command, by pinching it against the wall with the toe of the foot. This test is repeated 20 times.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Movement Imagery Questionnaire-3
It consists of 3 subscales evaluating external visual imagery, internal visual imagery and kinesthetic imagery and a total of 12 items. Before scoring each movement, the participant is asked to perform the movement and then the movement is imaged three times. Scoring is done between 1 and 7, with "1 point: very difficult to see/feel, 7 points: very easy to see/feel". A maximum score of 84 can be obtained on the MIQ-3 questionnaire. A higher score on the test means that the person has a better ability to visualize.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes
Vividness of Motion Imagery Questionnaire
In the Vividness of Movement Imagery questionnaire, the person does not need to perform the movements before visualizing them. This scale consists of four scenarios and you are asked to rank on a scale of one to five how vividly you picture them in the participant mind. Each scenario asks you to imagine the face of a loved one, a view of your favorite grocery store or a beautiful landscape and rate the vividness of the details in each scene. The individual is asked to imagine 4 scenarios first with eyes open and then with eyes closed. As a result of this situation, the individual can reach a maximum of 160 in total score.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes
Secondary outcomes (6)
Dalhousie Dyspnea and Perceived Exertion Scale
It consists of seven pictures each showing the three dyspnea constructs (chest tightness, throat closure and effort to breathe), plus an additional pictorial scale showing leg effort.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
6 Minute Walk Test
6MWT is defined as a submaximal test that can be easily applied in healthy or unhealthy individuals and is evaluated as an indicator of exercise capacity and walking capacity as well as many cardiovascular diseases. The 6MWT is referred to as the "Gold Standard" test of walking capacity. The aim of this test is to reach the longest possible walking distance at the end of six minutes. The standard protocol is applied in a 30-meter uninterrupted corridor or open area. It is recommended to repeat the 6MWT three times on the same day with a one-hour rest interval; the maximum walking distance is taken into account.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Quality of Life Scale for Children
This scale consists of a total of 23 items and 4 subscales, including 8 items measuring physical functioning, 5 items measuring emotional functioning, 5 items measuring social functioning and 5 items assessing school functioning. In the instructions in the scale, it is asked to determine how much the issue mentioned in the items has been a problem for the parent or child in the last month. Answers are given on a 5-point ordinal scale (0=never, 1=rarely, 2=sometimes, 3=often, 4=almost always). By inverting the scores (e.g. 0 → 100, 1 → 75, 2 → 50, 3 → 25, 4 → 0), a quality of life score between 0% and 100% is calculated for each section. A high score means that the participant has a high quality of life.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Tampa Kinesiophobia Scale
It is a 17-question scale developed to measure fear of movement/reinjury. The scale includes parameters of injury/re-injury and fear-avoidance in work-related activities. The scale uses a 4-point Likert scale (1=strongly disagree, 4=strongly agree). A high score on the scale indicates a high level of kinesiophobia. A score of 37 and above indicates kinesiophobia (fear of movement).
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Respiratory Function Test
Pulmonary function will be evaluated with a spirometer according to the American Thoracic Society and European Respiratory Society criteria. The device replaces the hand-held flow sensor, traditionally placed in the mouth, with the same sensor being secured to the face using straps and a mask. Participants will be asked to take a deep breath and then perform a strong and complete exhalation. This maneuver will be repeated three times, and the best of the three measurements, with a difference of less than 0.150 L between them, will be recorded. The participants; forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), Tiffeneau ratio (FEV1/FVC), peak expiratory flow (PEF), and forced expiratory flow at 25-75% (FEF25-75%) will be measured. When data such as age, gender, race, height, and weight are entered into the device, the expected values of all parameters will be calculated based on normative values.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Demographic and Clinical Data Collection Form
Participants; gender, date of birth, height in meters, weight in kilograms, body mass index in kg/m2, contact information, date and method of diagnosis, presence of chronic disease, medications/devices used, number of acute exacerbations and hospitalization history of the patient in the last year, presence of disease symptoms, previous surgery/trauma history, previous physiotherapy and rehabilitation program, background and family history information will be recorded.
Measured: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Oct 2024
- Study start5 Sep 2023
- Primary completion1 Jan 2024
- Study completion1 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for BronchiectasisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Atlas University
- Sponsor type
- University, hospital or other
- Collaborators
- Health Institutes of Turkey
- Responsible party
- Principal investigator, Hilal Denizoğlu Külli, Atlas University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06630403
- Sponsor's protocol ID
- Aysenur Temizel Tombul
- Status last verified
- Oct 2024
- First submitted
- 17 Sep 2024
- Last updated
- 8 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Motor Imagery, Cognitive Function and Reaction Time in Children With Bronchiectasis
- ClinicalTrials.gov ID
- NCT06630403
- Acronym / sponsor ID
- Aysenur Temizel Tombul
- Conditions
- Bronchiectasis
- Keywords
- bronchiectasis, cognitive function, motor imagery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Atlas UniversityUniversity, hospital or other
- Collaborators
- Health Institutes of Turkey
- Study start
- 5 Sep 2023 (actual)
- Primary completion
- 1 Jan 2024 (actual)
- Study completion
- 1 Jan 2024 (actual)
- First posted
- 8 Oct 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study was to evaluate motor imagery ability, reaction time and cognitive function parameters in children with CF and non-CF bronchiectasis compared to healthy peers.
Detailed description
The main causes affecting exercise capacity in patients with bronchiectasis are restriction of tidal expiratory flow, dyspnea secondary to dynamic hyperinflation, changes in pulmonary mechanics, inadequate gas exchange and decreased skeletal muscle mass. Due to all these symptoms, exercise capacity decreases in patients with bronchiectasis and the importance of physical activity increases. . In addition to decreased exercise capacity in individuals with bronchiectasis, studies on the effect of motor imagery ability, which is considered as a mental exercise, have not been found. Inadequate blood supply to the brain and muscle dysfunction have been reported to cause cognitive damage and decreased reaction time in COPD patients.
Study design
- Observational model
- Case-control
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Children with Bronchiectasis Experiment Group | – | Other: Demographic Data, Other: Disease History, Other: Pulmonary Function Test, Other: Reaction Time, Other: Functional Capacity, Other: Dyspnea Perception, Other: Quality of Life, Other: Fear of movement, Other: Ability of Motor Imagery, Other: Cognitive FunctionsChildren with bronchiectasis Participants will be required to sign an informed consent form before the evaluation. Assesment Methods: 1. Demographic data will be collected verbally. 2. The number of exacerbations in the last 1 year, hospitalization and medications used will be questioned. 3. Pulmonary Function Test will be applied. 4. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test. 5. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test. 6. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea. 7. Quality of life will be assessed with the "Quality of Life Scale for Children". 8. Fear of movement will be assessed with the Tampa Kinesiophobia Scale. 9. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery. 10. Cognitive functions will be assessed with Trail Making Test and Stroop Test. |
| Healthy Controls | – | Other: Demographic Data, Other: Pulmonary Function Test, Other: Reaction Time, Other: Functional Capacity, Other: Dyspnea Perception, Other: Quality of Life, Other: Fear of movement, Other: Ability of Motor Imagery, Other: Cognitive FunctionsHealthy Peers Participants will be required to sign an informed consent form before the evaluation. Assessment Methods: 1. Demographic data (age, height, weight, BMI) will be collected verbally via the assessment form. 2. Pulmonary Function Test will be applied. 3. Reaction time will be evaluated with the Nelson Hand-Foot Reaction Test. 4. Functional capacity of the patient will be evaluated with the 6 Minute Walk Test. 5. Dalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea. 6. Quality of life will be assessed with the "Quality of Life Scale for Children". 7. Fear of movement will be assessed with the Tampa Kinesiophobia Scale. 8. Motor Imagery ability will be assessed with the Movement Imagery Questionnaire-3, Vividness of Movement Imagery. 9. Cognitive functions will be assessed with Trail Making Test and Stroop Test. |
Who may qualify
- Ages
- 7 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- Twenty patients with bronchiectasis and 20 healthy individuals who met the inclusion criteria applied to the study. The study consisted of 2 groups, experimental and control.
Key inclusion criteria (5 listed)
- Diagnosed with cystic or non-cystic bronchiectasis
- Being clinically stable
- Not having an exacerbation or infection
- Being between the ages of 7-18
- To be able to read and understand Turkish
Key exclusion criteria (4 listed)
- Unstable concomitant cardiac, orthopedic or neurologic disease
- History of previous lung or liver transplantation
- History of acute exacerbation and/or hospitalization in the last 1 month
- Changes in medical treatment during the study period.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Demographic DataDemographic data (age, height, weight, BMI) will be collected verbally through an assessment form. | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Disease HistoryThe number of exacerbations in the last 1 year, hospitalization and medications used will be questioned. | Other | Children with Bronchiectasis Experiment Group |
| Pulmonary Function TestPulmonary Function Test will be performed with a spirometer. | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Reaction TimeReaction time will be evaluated with the Nelson Hand-Foot Reaction Test. | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Functional CapacityFunctional capacity will be evaluated with 6 minute walk test | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Dyspnea PerceptionDalhousie Dyspnea and Perceived Exertion Scale will be used to determine the level of dyspnea | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Quality of LifeQuality of life will be assessed with the "Quality of Life Scale for Children\" | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Fear of movementFear of movement will be evaluated with Tampa Kinesiophobia Scale | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Ability of Motor ImageryMotor Imagery ability will be assessed by Movement Imagery Questionnaire-3 and Vividness of Movement Imagery | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
| Cognitive FunctionsCognitive functions will be assessed with Trail Making Test and Stroop Test | Other | Children with Bronchiectasis Experiment Group, Healthy Controls |
Primary outcome
Trail Making Test
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
The Trail Making Test is divided into two parts. In the first part, the participant is asked to connect the 23 numbers in the circle randomly placed on the page with a pencil in an orderly order, and in the second part, the participant is asked to draw and connect the 23 numbers and letters in the circle in a mixed order. In the second part, the individual has to change sets between one letter and one number. (1- A, 2-B, 3-C, 4-D, etc.).The test can be applied between the ages of 8-79.
Stroop Test
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
The Stroop Test consists of four parts. The first part contains words written in black (e.g blue), the second part contains colors and the last part contains words written in different colors (e.g. the word blue written in red ink). The participant is expected to fulfill these tasks in turn. The participant has to correctly read the words in the first part, say the colors in the next part, read the colored word in the third part, and then say the color in which the word is written in the last part.
Nelson Hand Reaction Test
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
The tester holds the ruler by the tip and between the thumb and index fingers of the subject and releases the ruler. When the ruler is released, the participant is asked to catch the ruler. The participants hand is fixed and 20 trials are performed in the test. At the top point where the subject grabs the ruler with his/her fingers, the reaction time of the subject is determined. The highest and lowest five trials are discarded and the remaining ones are averaged.
Nelson Foot Reaction Test
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
The participant removes his/her shoes and sits with the toe 2.5 cm from the wall and the heel 5 cm. The tester holds the reaction time ruler at the edge of the wall and between the wall and the subjects foot, with the baseline at the tip of the thumb. The subject is instructed to look at the concentration line and to hold the ruler, which falls after the ready command, by pinching it against the wall with the toe of the foot. This test is repeated 20 times.
Movement Imagery Questionnaire-3
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes
It consists of 3 subscales evaluating external visual imagery, internal visual imagery and kinesthetic imagery and a total of 12 items. Before scoring each movement, the participant is asked to perform the movement and then the movement is imaged three times. Scoring is done between 1 and 7, with "1 point: very difficult to see/feel, 7 points: very easy to see/feel". A maximum score of 84 can be obtained on the MIQ-3 questionnaire. A higher score on the test means that the person has a better ability to visualize.
Vividness of Motion Imagery Questionnaire
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes
In the Vividness of Movement Imagery questionnaire, the person does not need to perform the movements before visualizing them. This scale consists of four scenarios and you are asked to rank on a scale of one to five how vividly you picture them in the participant mind. Each scenario asks you to imagine the face of a loved one, a view of your favorite grocery store or a beautiful landscape and rate the vividness of the details in each scene. The individual is asked to imagine 4 scenarios first with eyes open and then with eyes closed. As a result of this situation, the individual can reach a maximum of 160 in total score.
6 secondary outcomes
Dalhousie Dyspnea and Perceived Exertion Scale
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
6 Minute Walk Test
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Quality of Life Scale for Children
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Tampa Kinesiophobia Scale
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Respiratory Function Test
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Demographic and Clinical Data Collection Form
Time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2024.
Related trials for Bronchiectasis
RecruitingPhase 2
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
Non-cystic Fibrosis Bronchiectasis
Recruiting
THERMotherapy Against Persistent Bacterial LUNG Infections
Lung Diseases, Obstructive, Bronchiectasis
RecruitingObservational study
Natural History of Bronchiectasis
Bronchiectasis, Cystic Fibrosis
RecruitingPhase 1
Investigation of Pharmacokinetics, Safety of HSK31858 in Subjects With Renal Impairment
Non-cystic Fibrosis Bronchiectasis (NCFBE)
Not yet recruitingPhase 3
A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)
Bronchiectasis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Bronchiectasis, run by Atlas University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Trail Making Test (time frame: The assessment will be administered only once to each participant. All tests will take place on the same day and will last approximately 60 minutes.). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2024.